To Be Free and Normal: Addiction, Governance, and the Therapeutics of Buprenorphine
Author:
- 23 June 2015
- journal article
- research article
- Published by Wiley in Medical Anthropology Quarterly
- Vol. 29 (4) , 512-530
Abstract
Methadone maintenance has dominated opiate addiction treatment in the United States for decades. Since 2002, opiate addiction has also been treated in general medical settings with a substance called buprenorphine. Based on interviews and participant observation conducted in northern California, this article analyzes how discourses of freedom and normalcy in patient and provider narratives reflect and affect experiences with this treatment modality. I discuss how buprenorphine treatment, in contrast to methadone maintenance, offers patients and providers a greater sense of autonomy and flexibility in how they receive and deliver treatment. It presents them with new obligations, responsibilities, and choices around care and conduct. It simultaneously perpetuates and shapes a desire to be “free” and “normal.” I argue that the therapeutics of buprenorphine govern patients and providers through this desire for freedom and normalcy. Buprenorphine is thus a technology of governmentality that extends neoliberal discourses and values and produces self‐governing subjects.Keywords
This publication has 33 references indexed in Scilit:
- The history of the development of buprenorphine as an addiction therapeuticAnnals of the New York Academy of Sciences, 2012
- Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: BuprenorphineJournal of Addictive Diseases, 2010
- ‘Civilizing technologies’ and the control of devianceBioSocieties, 2010
- An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and researchJournal of Substance Abuse Treatment, 2005
- Consumption and its discontents: addiction, identity and the problems of freedomThe British Journal of Sociology, 2004
- Diffusion of Substance Abuse Treatment: Will Buprenorphine be a Success?Journal of Psychoactive Drugs, 2004
- From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United StatesDrug and Alcohol Dependence, 2003
- MethadoneSocial Studies of Science, 2002
- Office-Based Treatment for Opioid Dependence: Reaching New Patient PopulationsAmerican Journal of Psychiatry, 2001
- Caring, Control, and Clinicians' Influence: Ethical Dilemmas in Development DisabilitiesEthics & Behavior, 1999